1830O - Liquid biopsy as tool to monitor and predict clinical benefit from chemotherapy (CT) and immunotherapy (IT) in advanced non-small cell lung cancer (aNSCLC): A prospective study

L Bonanno,E Zulato,I Attili,A Pavan,P Del Bianco,G Nardo,M Verza,L Pasqualini,G Pasello,G Zago,S Frega,M Fassan,F Calabrese,A Amadori,V Guarneri,P.F Conte,S Indraccolo

doi:10.1093/annonc/mdy303

1830O - Liquid biopsy as tool to monitor and predict clinical benefit from chemotherapy (CT) and immunotherapy (IT) in advanced non-small cell lung cancer (aNSCLC): A prospective study

L Bonanno, E Zulato + Show 15 more

Open Access

https://doi.org/10.1093/annonc/mdy303

Copy DOI

Journal: Annals of oncology : official journal of the European Society for Medical Oncology	Publication Date: Oct 1, 2018
Citations: 7	License type: publisher-specific-oa

Affiliation: Istituto Oncologico Veneto, Istituti di Ricovero e Cura a Carattere Scientifico, University of Padua, Azienda Ospedaliera Universitaria Pisana

#Advanced Non-small Cell Lung Cancer #Immunotherapy In Advanced Cancer + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

1830O - Liquid biopsy as tool to monitor and predict clinical benefit from chemotherapy (CT) and immunotherapy (IT) in advanced non-small cell lung cancer (aNSCLC): A prospective study

Full Text